propranolol has been researched along with Chronic Hepatitis C in 9 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol bears antioxidant, anti-inflammatory, and antiangiogenic properties and antitumoral effects and therefore is potentially active in the prevention of hepatocellular carcinoma (HCC)." | 7.78 | Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. ( Aout, M; Beaugrand, M; Bourcier, V; Ganne-Carrie, N; Grando-Lemaire, V; Mahmoudi, A; Nkontchou, G; Roulot, D; Trinchet, JC; Vicaut, E, 2012) |
| "A case of angioedema secondary to propranolol therapy in a patient with chronic hepatitis C virus (HCV) infection is reported." | 7.76 | Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection. ( Artacho-Criado, S; Dorantes-Calderon, B; Grande-Santamaria, L; Márquez-Saavedra, E; Morillo-Verdugo, R; Romero-Gómez, M, 2010) |
| "Sofosbuvir is a direct-acting antiviral drug used to treat chronic hepatitis C infection." | 3.85 | Ventricular Extrasystoles after First Dose of Sofosbuvir in a Patient Treated with Propranolol but not with Amiodarone: A Case Report. ( Baghazza, S; Bencherif, R; Chaabna, K; Djezzar, S; Guehimeche, R; Mallem, D; Rouabhia, S; Sadelaoud, M; Sadouki, H, 2017) |
| "Propranolol bears antioxidant, anti-inflammatory, and antiangiogenic properties and antitumoral effects and therefore is potentially active in the prevention of hepatocellular carcinoma (HCC)." | 3.78 | Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. ( Aout, M; Beaugrand, M; Bourcier, V; Ganne-Carrie, N; Grando-Lemaire, V; Mahmoudi, A; Nkontchou, G; Roulot, D; Trinchet, JC; Vicaut, E, 2012) |
| " In this issue of the journal (beginning on page 1007), Nkontchou and colleagues report their retrospective observational finding that the β-blocker propranolol was associated with a highly statistically significant reduction in the incidence of hepatocellular carcinoma in patients with advanced cirrhosis and related esophageal varices." | 3.78 | Can propranalol prevent hepatocellular carcinoma? ( London, WT; McGlynn, KA, 2012) |
| "A case of angioedema secondary to propranolol therapy in a patient with chronic hepatitis C virus (HCV) infection is reported." | 3.76 | Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection. ( Artacho-Criado, S; Dorantes-Calderon, B; Grande-Santamaria, L; Márquez-Saavedra, E; Morillo-Verdugo, R; Romero-Gómez, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, EH | 1 |
| Guo, XR | 1 |
| Wang, JT | 1 |
| Hu, QG | 1 |
| Li, JH | 1 |
| Tang, QY | 1 |
| Zu, HM | 1 |
| Huan, H | 1 |
| Wang, Y | 1 |
| Gao, YF | 1 |
| Hu, GQ | 1 |
| Li, W | 1 |
| Liu, ZJ | 1 |
| Ma, QP | 1 |
| Song, YL | 1 |
| Yang, JH | 1 |
| Zhu, Y | 1 |
| Huang, SD | 1 |
| Meng, ZJ | 1 |
| Bai, B | 1 |
| Chen, YP | 1 |
| Gao, C | 1 |
| Huang, MX | 1 |
| Jin, SQ | 1 |
| Lu, MZ | 1 |
| Xu, Z | 1 |
| Zhang, QH | 1 |
| Zheng, S | 1 |
| Zeng, QL | 1 |
| Qi, XL | 1 |
| Rouabhia, S | 1 |
| Baghazza, S | 1 |
| Sadouki, H | 1 |
| Djezzar, S | 1 |
| Bencherif, R | 1 |
| Guehimeche, R | 1 |
| Sadelaoud, M | 1 |
| Mallem, D | 1 |
| Chaabna, K | 1 |
| Abd Alla, MD | 1 |
| Eid, EMM | 1 |
| Soliman, AIA | 1 |
| Elhawary, MA | 1 |
| Kilany, YF | 1 |
| Abd-Almonaem, G | 1 |
| Bayoumi, SS | 1 |
| Moursy, MRA | 1 |
| Al-Zaem, FAM | 1 |
| Márquez-Saavedra, E | 1 |
| Artacho-Criado, S | 1 |
| Morillo-Verdugo, R | 1 |
| Grande-Santamaria, L | 1 |
| Dorantes-Calderon, B | 1 |
| Romero-Gómez, M | 1 |
| Kim, BK | 1 |
| Choi, YS | 1 |
| Park, YH | 1 |
| Lee, SU | 1 |
| Nkontchou, G | 1 |
| Aout, M | 1 |
| Mahmoudi, A | 1 |
| Roulot, D | 1 |
| Bourcier, V | 1 |
| Grando-Lemaire, V | 1 |
| Ganne-Carrie, N | 1 |
| Trinchet, JC | 1 |
| Vicaut, E | 1 |
| Beaugrand, M | 1 |
| London, WT | 1 |
| McGlynn, KA | 1 |
| Yang, WS | 1 |
| Chu, PL | 1 |
| Liu, CH | 1 |
| Chung, GB | 1 |
| Wu, KD | 1 |
| Perelló, A | 1 |
| Escorsell, A | 1 |
| Bru, C | 1 |
| Gilabert, R | 1 |
| Moitinho, E | 1 |
| García-Pagán, JC | 1 |
| Bosch, J | 1 |
1 trial available for propranolol and Chronic Hepatitis C
| Article | Year |
|---|---|
PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Administration Schedule; Drug Ther | 2016 |
8 other studies available for propranolol and Chronic Hepatitis C
| Article | Year |
|---|---|
[Investigate of the etiology and prevention status of liver cirrhosis].
Topics: Carvedilol; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases, Alc | 2023 |
Ventricular Extrasystoles after First Dose of Sofosbuvir in a Patient Treated with Propranolol but not with Amiodarone: A Case Report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antiviral Agents; Dose-Response Relationship, Drug; Echoca | 2017 |
Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection.
Topics: Angioedema; Anti-Arrhythmia Agents; Female; Hepatitis C, Chronic; Humans; Middle Aged; Propranolol; | 2010 |
Interferon-alpha-induced destructive thyroiditis followed by Graves' disease in a patient with chronic hepatitis C: a case report.
Topics: Adult; Antiviral Agents; Female; Graves Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Met | 2011 |
Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis.
Topics: Aged; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Human | 2012 |
Can propranalol prevent hepatocellular carcinoma?
Topics: Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; M | 2012 |
Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Antiviral Agents; Carbimazole; Drug Therapy, | 2008 |
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
Topics: Adult; Fatty Liver, Alcoholic; Female; Hepatic Veins; Hepatitis C, Chronic; Humans; Liver Cirrhosis; | 1999 |